Society guideline links: Heparin-induced thrombocytopenia (HIT)

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Anticoagulation".)

Links to guidelines related to coronavirus disease 2019 (COVID-19), including VITT, are also provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics" and "Society guideline links: COVID-19 – General guidelines for vaccination", section on 'Vaccine-induced immune thrombotic thrombocytopenia (VITT)'.)

International

●International Society on Thrombosis and Haemostasis (ISTH): Communication on heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing (2016)

●Neurocritical Care Society (NCS) and Society of Critical Care Medicine (SCCM): Guideline for reversal of antithrombotics in intracranial hemorrhage (2016)

Canada

●Thrombosis Canada: Heparin-induced thrombocytopenia (HIT) (2021)

United States

●American Society of Hematology (ASH): Guidelines for management of venous thromboembolism – Heparin-induced thrombocytopenia (2018)

●American College of Chest Physicians (CHEST): Evidence-based clinical practice guidelines for treatment and prevention of heparin-induced thrombocytopenia – Antithrombotic therapy and prevention of thrombosis, 9th edition (2012)

United Kingdom

●British Society of Haematology (BSH): Guidelines on the diagnosis and management of heparin-induced thrombocytopenia, 2nd edition (2012)

Australia–New Zealand

●Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ): A consensus statement for the diagnosis and management of heparin-induced thrombocytopenia (2019)